| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50090-6931-0 | 50090-6931 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20231214 | N/A | ANDA | ANDA040707 | A-S Medication Solutions | HYDROCHLOROTHIAZIDE | 12.5 mg/1 | 90 TABLET in 1 BOTTLE (50090-6931-0) |
| 0228-2820-96 | 0228-2820 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20231201 | 20270630 | ANDA | ANDA040707 | Actavis Pharma, Inc. | HYDROCHLOROTHIAZIDE | 12.5 mg/1 | 1000 TABLET in 1 BOTTLE (0228-2820-96) |
| 0228-2820-11 | 0228-2820 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20070312 | 20270630 | ANDA | ANDA040707 | Actavis Pharma, Inc. | HYDROCHLOROTHIAZIDE | 12.5 mg/1 | 100 TABLET in 1 BOTTLE (0228-2820-11) |
| 68071-3443-3 | 68071-3443 | HUMAN PRESCRIPTION DRUG | Hydrochlorothiazide | Hydrochlorothiazide | TABLET | ORAL | 20230621 | N/A | ANDA | ANDA040707 | NuCare Pharmaceuticals,Inc. | HYDROCHLOROTHIAZIDE | 12.5 mg/1 | 30 TABLET in 1 BOTTLE (68071-3443-3) |